These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29682200)

  • 1. Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells.
    Huang MB; Giesler KE; Katzman BM; Prosser AR; Truax V; Liotta DC; Wilson LJ; Bond VC
    Oncotarget; 2018 Mar; 9(24):16996-17013. PubMed ID: 29682200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast Cancer.
    Bumpers H; Huang MB; Katkoori V; Manne U; Bond V
    J Cancer Ther; 2013 Jun; 4(4):898-906. PubMed ID: 25285238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Nef-CXCR4 interactions important for apoptosis induction.
    Huang MB; Jin LL; James CO; Khan M; Powell MD; Bond VC
    J Virol; 2004 Oct; 78(20):11084-96. PubMed ID: 15452229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.
    James CO; Huang MB; Khan M; Garcia-Barrio M; Powell MD; Bond VC
    J Virol; 2004 Mar; 78(6):3099-109. PubMed ID: 14990729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic peptides derived from HIV-1 Nef induce lymphocyte depletion in mice.
    Huang MB; James CO; Powell MD; Bond VC
    Ethn Dis; 2008; 18(2 Suppl 2):S2-30-7. PubMed ID: 18646317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes.
    Sloan RD; Donahue DA; Kuhl BD; Bar-Magen T; Wainberg MA
    Retrovirology; 2010 May; 7():44. PubMed ID: 20465832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Nef promotes migration and chemokine synthesis of human basophils and mast cells through the interaction with CXCR4.
    Rossi FW; Prevete N; Rivellese F; Lobasso A; Napolitano F; Granata F; Selleri C; de Paulis A
    Clin Mol Allergy; 2016; 14():15. PubMed ID: 27822141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
    Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
    Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
    Rhodes LV; Bratton MR; Zhu Y; Tilghman SL; Muir SE; Salvo VA; Tate CR; Elliott S; Nephew KP; Collins-Burow BM; Burow ME
    Exp Cell Res; 2011 Nov; 317(18):2573-81. PubMed ID: 21906588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.
    Venzke S; Michel N; Allespach I; Fackler OT; Keppler OT
    J Virol; 2006 Nov; 80(22):11141-52. PubMed ID: 16928758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Nef-M1 Effects on Colorectal Cancer Growth in Tumor-induced Spleens and Hepatic Metastasis.
    Harrington W; Bond V; Huang MB; Powell M; Lillard J; Manne U; Bumpers H
    Mol Cell Pharmacol; 2009 Aug; 1(2):85-91. PubMed ID: 20383296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proline-rich region of HIV-1 Nef affects CXCR4-mediated chemotaxis in Jurkat T cells.
    Lee CM; Gala S; Stewart GJ; Williamson P
    Viral Immunol; 2008 Sep; 21(3):347-54. PubMed ID: 18707241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Nef down-modulates C-C and C-X-C chemokine receptors via ubiquitin and ubiquitin-independent mechanism.
    Chandrasekaran P; Moore V; Buckley M; Spurrier J; Kehrl JH; Venkatesan S
    PLoS One; 2014; 9(1):e86998. PubMed ID: 24489825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nef from SIV(mac239) decreases proliferation and migration of adenoid-cystic carcinoma cells and inhibits angiogenesis.
    Cai C; Rodepeter FR; Rossmann A; Teymoortash A; Lee JS; Quint K; Di Fazio P; Ocker M; Werner JA; Mandic R
    Oral Oncol; 2011 Sep; 47(9):847-54. PubMed ID: 21763177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection.
    Mwimanzi P; Hasan Z; Tokunaga M; Gatanaga H; Oka S; Ueno T
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):422-7. PubMed ID: 21093412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
    Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
    FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.
    Toyoda M; Ogata Y; Mahiti M; Maeda Y; Kuang XT; Miura T; Jessen H; Walker BD; Brockman MA; Brumme ZL; Ueno T
    J Virol; 2015 Sep; 89(18):9639-52. PubMed ID: 26178998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Nef inhibits T cell migration.
    Choe EY; Schoenberger ES; Groopman JE; Park IW
    J Biol Chem; 2002 Nov; 277(48):46079-84. PubMed ID: 12354773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.